Practicum Journal: Safe Prescribing

/in /by

There is probably no greater responsibility that the psychiatric mental health nurse practitioner (PMHNP) assumes than the responsibility of prescribing medications. While someone can be harmed by psychotherapy, the level and intensity of the harm generally does not come to the same level of harm that can occur from improper prescribing. The PMHNP must understand his/her responsibility both at a state and federal level when it comes to prescribing medications.

In this Practicum Journal Assignment, you will explore the legalities associated with prescribing controlled substances, as well as what a DEA number is, how to obtain one, and, most importantly, how to prescribe controlled substances in your state.

Learning Objectives

· Analyze roles of the Drug Enforcement Administration

· Analyze PMHNP responsibilities when issued a DEA number

· Analyze DEA number application procedures

· Analyze state requirements for safe prescribing and prescription monitoring

· Analyze PMHNP responsibilities for safe prescribing and prescription monitoring

· Analyze Schedule II-V drug levels

                                    ASSIGNMENT

To prepare for this Practicum Journal:

· Review the Learning Resources.

In 2-3 pages:

· Describe the role of the Drug Enforcement Administration (DEA) as it pertains to

the Psychiatric mental health nurse practitioner (PMHNP).

· Explain your responsibilities when having a DEA number.

· Explain how you apply for a DEA number.

· Explain your state’s requirements (TEXAS) for a safe prescribing and prescription monitoring program. Explain your responsibility as a PMHNP to follow these requirements.

· Provide an example of a drug you may prescribe from each of the Schedule II-V drug levels.

N: B PLEASE INCLUDE INTRODUCTION, CONCLUSION AND REFERENCES LESS THAN 5 YEARS OLD

                                                        Learning Resources

Required Readings

Stahl, S. M. (2014). Prescriber’s Guide: Stahl’s Essential Psychopharmacology (5th ed.). New York, NY: Cambridge University Press.

http://ezp.waldenulibrary.org/login?url=http://stahlonline.cambridge.org/

To access information on specific medications, click on The Prescriber’s Guide, 5th Ed. tab on the Stahl Online website and select the appropriate medication.

Depression

Premenstrual dysphoric disorder

Seasonal affective disorder (MDD with Seasonal Variation)

agomelatine

amisulpride

amitriptyline

amoxapine

amphetamine (d)

amphetamine (d,l)

aripiprazole (adjunct)

asenapine

atomoxetine

bupropion

buspirone (adjunct)

citalopram

clomipramine

cyamemazine

desipramine

desvenlafaxine

dothiepin

paroxetine

phenelzine

protriptyline

quetiapine (adjunct)

reboxetine

selegiline

sertindole

sertraline

sulpiride

tianeptine

tranylcypromine

triiodothyronine

trazodone

trimipramine

venlafaxine

vilazodone

vortioxetine

doxepin

duloxetine

escitalopram

fluoxetine

flupenthixol

fluvoxamine

iloperidone

imipramine

isocarboxazid

ketamine

lisdexamfetamine

lithium (adjunct)

l-methylfolate (adjunct)

lofepramine

lurasidone

maprotiline

methylphenidate (d)

methylphenidate (d,l)

mianserin

milnacipran

mirtazapine

moclobemide

modafinil (adjunct)

nefazodone

nortriptyline

olanzapine

citalopram

desvenlafaxine

escitalopram

fluoxetine

paroxetine

sertraline

venlafaxine

bupropion